Search bioRxiv⌕ Search

Biology subjects

Shmal, D.

Publications and source records attributed to Shmal, D..

2 recordsLinked to original sources

REST/NRSF phosphorylation by CaMKIV regulates its transcriptional repressor activity and half-life

REST is a repressor of a large cluster of neural genes that homeostatically regulates neural activity. However, whether REST can be regulated by Ca2+ and Ca2+-activated kinases is unknown. We investigated Ca2+/calmodulin-dependent protein kinases (CaMKs) as upstream regulators of REST fate and activity. We show that REST is phosphorylated by CaMKIV at Ser-322 site located within the linker between the 5th-6th Zn-finger domains. Phosphomimic REST mutant in Serine-322 decreased REST repressor activity and caused its transition from nucleus to cytosol, followed by degradation. Molecular dynamics simulations of the phosphomimic N-terminal REST and the DNA RE1 sequence revealed a sharp decrease in the stability of the REST-RE1 binding interface. Moreover, the homeostatic effects of CaMKIV on the amplitude of excitatory synaptic currents were inhibited by the genetic deletion of REST. The results demonstrate that CaMKIV phosphorylation has a crucial role in the homeostatic regulation of REST levels and repressor activity. TeaserCaMKIV phosphorylation homeostatically regulates the repressor activity of REST on neural genes and its half-life.

neuroscience↗

P3HT-GRAPHENE DEVICE FOR THE RESTORATION OF VISUAL PROPERTIES IN A RAT MODEL OF RETINITIS PIGMENTOSA

Retinal degeneration is one of the prevalent causes of blindness worldwide, for which no effective treatment has yet been identified. Inorganic photovoltaic devices have been investigated for visual restoration in advanced stage Retinitis pigmentosa (RP), although lack of implant flexibility and foreign-object reactions have limited their application. Organic photoactive retinal prostheses may overcome these limitations, being biomimetic and tissue friendly. Inspired by organic photovoltaic strategies involving graphene, a hybrid retinal prosthesis was recently engineered consisting of a dual poly-3-hexylthiophene (P3HT) and graphene layer onto a flexible substrate. Here, this hybrid prosthesis was subretinally implanted in vivo in 5-month-old Royal College of Surgeons (RCS) rats, a rodent model of RP. Implanted dystrophic rats restored visual performances at both subcortical and cortical levels in response to light stimuli, in the absence of marked inflammatory responses. Moreover, the analysis of the physical-mechanical properties after prolonged permanence in the eye showed excellent biocompatibility and robustness of the device. Overall, the results demonstrate that graphene-enhanced organic photovoltaic devices can be suitably employed for the rescue of retinal dystrophies and supports the translation of the organic strategy into the medical practice. TABLE OF CONTENTSInspired by organic photovoltaic, a hybrid retinal prosthesis consisting of poly-3-hexylthiophene (P3HT) and graphene on a flexible substrate was subretinally implanted in vivo in Royal College of Surgeons (RCS) rats, a model of Retinitis pigmentosa. Implanted dystrophic rats restored visual performances at both subcortical and cortical levels in response to light stimuli, in the absence of marked inflammatory responses. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=37 SRC="FIGDIR/small/507903v1_ufig1.gif" ALT="Figure 1"> View larger version (16K): org.highwire.dtl.DTLVardef@1cb30a0org.highwire.dtl.DTLVardef@e57c2corg.highwire.dtl.DTLVardef@3b3c8corg.highwire.dtl.DTLVardef@10442d7_HPS_FORMAT_FIGEXP M_FIG C_FIG

neuroscience↗